Text and Data Mining valid from 2020-02-13
First Online: 13 February 2020
Compliance with Ethical Standards
: The studies involving selatogrel discussed in this review were funded by Idorsia Pharmaceuticals Ltd.
: Uta Schilling is a full-time employee of Idorsia Pharmaceuticals Ltd. Mike Ufer and Jasper fDingemanse are full-time employees of Idorsia Pharmaceuticals Ltd and owners of stocks/ stock options. Selatogrel is currently in development by Idorsia Pharmaceuticals Ltd. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the article.